A moment to celebrate a potentially revolutionary cancer blood test trial
NHS England started a large-scale trial of a new blood [...]
Health-related quality of life with lenvatinib in combination with everolimus
Maintaining good health-related quality of life is important for all [...]
Nivolumab compared to cabozantinib as a second- or third-line treatment
This study looked at real world data from people with [...]
Attitudes towards pharmaceutical companies in the UK
A recent survey from the Association of the British Pharmaceutical [...]
Cabozantinib plus nivolumab and ipilimumab delays progression in kidney cancer
Preliminary results from the COSMIC-313 clinical trial have ben released. [...]
Surgical treatment of metastatic kidney cancer
There were a number of studies presented at the European [...]
Statins improve the effectiveness of nivolumab for advanced kidney cancer
Statins are a group of medicines that can help lower [...]
Incidence and risk of unplanned conversion from partial to radical nephrectomy
Partial nephrectomy, where the part of the kidney containing the [...]
Shared decision-making in kidney cancer
There was an interesting talk about shared decision-making for kidney [...]
Age differences in patient-reported experience of diagnosis, management, and burden of kidney cancer
Data from the second biennial worldwide International Kidney Cancer Coalition [...]
